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Formation of nonspecific precipitants in sera in different kinds of agarose and
batches ofbarbital buffer by routine counterimmunoelectrophoresis was observed.
These nonspecific precipitants consistently locating at the cathodal side of the
well upon counterimmunoelectrophoresis can lead to the incorrect interpretation
that a specific antibody is present in the patient's serum against the antigens
tested. This observation indicates the importance of including a negative control
(patient's serum atone) with each individual sample tested by counterinmuno-
electrophoresis for the detection of specific antibody to reduce false-positives.
Patients with staphylococcal endocarditis and
bacteremia frequently respond with high titers
of antiteichoic acid antibody (ATA). The detec-
tion ofATA in patients can serve, in many cases,
as an important adjunct to cultures for the di-
agnosis of staphylococcal infection. High titers
of ATA can be especially useful when cultures
are difficult to obtain or when the interpretation
of culture is complicated by previous antibiotic
therapy (1, 2, 6). Currently, many methods, in-
cluding gel diffusion, counterimmunoelectro-
phoresis (CIE), enzyme-linked immunosorbent
assay, and radioimmunoassay, have been used
for the detection of ATA (4, 5, 7). CIE, a rapid
procedure, has been widely used in many labo-
ratories to detect bacterial antigens. In our lab-
oratories, when CIE is used to detect the pres-
ence of bacterial antigens in patients' serum, the
formation of an additional precipitant on the
cathodal side of the patient's serum well is some-
times seen. This additional precipitant, formed
outside of the area between the cathodal and
anodal wells, did not seem to be a specific anti-
gen-antibody precipitant because it was some-
times seen in sera which were free of any bac-
terial antigens. This led us to examine the fre-
quency and consistency of the formation of non-
specific precipitants in some sera upon routine
CIE.
MATERLALS AND METHODS
Media and buffers. Different kinds of agarose
obtained from the following companies were used:
BBL Microbiology Systems, Cockeysville, Md. (lot
501600); Difco Laboratories, Detroit, Mich. (Noble, lot
616470); Marine Colloids, Rockland, Maine (Seakem,
lot 60136); and GIBCO Laboratories, Grand Island,
N.Y. (lot A452365).
Barbital buffers were made up with calcium lactate
pentahydrate (Fisher Scientific Co., Fair Lawn, N.J.,
lot 780899), barbital sodium (Fisher Scientific Co., lot
783514 or 774675), and barbitals (Fisher Scientific Co.,
lot 740822 or Sigma Chemical Co., St. Louis, Mo., lot
108C-0506). Continuous CIE was employed, in which
gels at a concentration of 0.75% were prepared in 0.05
M barbital buffer at pH 8.6, and the same buffer was
used in the electrophoresis chamber reservoirs.
Samples. Sera were obtained from normal human
blood donors; urine and cerebrospinal fluid were ob-
tained from routine samples coming into the labora-
tory.
CIE procedure. The method of CIE was similar to
that of Leffell et al. (3). CIE was performed in an
electrophoresis unit (MRA Corp., Boston, Mass.) at
room temperature, and current was supplied by a
Beckman Duostate (Beckman Instruments, Inc., Ful-
lerton, Calif.) which could deliver either constant volt-
age or constant current. Plastic plates (15 by 100 mm;
Lab-Tek Products, Div. Miles Laboratories Inc., Na-
perville, 11.) coated with 15 ml of agarose were used.
Paired wells 2 mm in diameter were cut 3 mm apart.
The procedure used to test sera for the formation of
nonspecific precipitants was similar to the routine
procedure used to detect the presence of ATA. Sera
to be tested were placed in the anodal wells and
subjected to 15 min of electrophoresis before the ad-
dition of either distilled water or barbital buffer to the
cathodal well. The plates were run at 150 V constant
voltage for a total of 35 min. The electric circuit was
completed with wicks made up ofWhatman no. 3 filter
paper (Whatman, Clifton, N.J.). After electrophoresis,
the plates were flooded with cold normal saline and
precipitant formation was observed under indirect
light immediately and after overnight incubation. Fi-
nal readings were made from the overnight incubation
at 4°C.
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RESULTS
Nonspecific precipitants formed in normal se-
rum alone upon CIE were seen with all of the
different kinds of agarose and batches of barbital
buffer used in this study (Table 1). However,
when 40 samples of cerebrospinal fluid or urine
were run in the same routine, 98% of the samples
failed to show any kind ofnonspecific precipitant
with any of the agarose and buffer systems used.
DISCUSSION
The detection of ATA in patients' serum by
CIE can be used as an important adjunct to
cultures in the diagnosis of some forms of staph-
ylococcal infection. In our CIE system, the lo-
cating of nonspecific precipitants at the cathodal
side of the well was observed with some sera
alone (Fig. 1). The consistent locating of this
nonspecific precipitant band at the cathodal side
of the well with some sera may not interfere
with the interpretation, if the presence of bac-
terial antigens is studied. This is because the
patient's serum would be put at the cathodal
well, and the nonspecific precipitant line, if pres-
ent, wiil form outside the area in which a specific
antigen-antibody precipitant would normally be
expected. However, if one is testing for the pres-
ence of a specific antibody (e.g., ATA or candida
antibody) in the serum, caution should be exer-
cised in the search for the specific antigen-anti-
body precipitant because the patient's serum
would be located at the anodal well. The non-
specific precipitant formed around the area in
which the specific antigen-antibody precipitant
is normally observed may obscure the interpre-
tation. The reason for the high percentage of
TABLE 1. Effect of different batches of barbital
buffer and supporting agarose on nonspecific
precipitant formation in normal sera by CIE




Noble 352 258 (73)
GIBCO 374 269 (72)
Seakem 339 96 (28)
2b
Noble 308 255 (83)
GIBCO 308 213 (69)
Seakem 308 78 (25)
BBL 308 175 (67)
a Batch 1 was made with Fisher barbital sodium C-
IV lot 783514 and Fisher barbital C-IV lot 740832.
b Batch 2 was made with Fisher barbital sodium C-
IV lot 774675 and Sigma barbital lot 108C-0506.
FIG. 1. Nonspecific precipitant formation with
normal human sera A, B, and C, but not D and E,
upon the completion of CIE.
nonspecific precipitants observed in this system
with sera but rarely with urine and CSF could
be due to the presence of cryoglobulins or other
precipitable proteins in some of the sera em-
ployed in this study. It may also be due to the
possibility that, in some of the sera used in this
study, there were pre-existing antibodies which
recognize antigens present in the agars or
buffers. This observation of nonspecific precipi-
tants in certain sera in different agarose prepa-
rations and different buffers indicates the im-
portance of running a negative control (patient's
serum alone) to cover the possibility that the
nonspecific precipitant may also form occasion-
ally in other CIE procedures. This inclusion of
a negative control will allow us to make a better
judgement in cases where the nonspecific precip-
itant resembles the specific antigen-antibody
precipitant. The benefit of inclusion of a nega-
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tive control can also apply to the detection of
any specific antibody in patients' serum by CIE.
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